Global Exosomes Supply, Demand and Key Producers, 2026-2032
The global Exosomes market size is expected to reach $ 1986 million by 2032, rising at a market growth of 15.0% CAGR during the forecast period (2026-2032).
Exosomes are nanoscale extracellular vesicles with diameters of approximately 30–150 nanometers, secreted by various cell types through exocytosis under physiological or pathological conditions. Found in biological fluids such as blood, urine, and cerebrospinal fluid, they carry a wide range of biomolecules including proteins, lipids, DNA, mRNA, and miRNA, playing a key role in intercellular communication, immune regulation, tumor progression, tissue repair, and neurodegenerative disease pathways. Advances in nanoscale isolation technologies, biomarker identification, and high-throughput omics research have positioned exosomes as powerful tools for liquid biopsy and early disease diagnosis, as well as promising vectors for targeted drug delivery, immune modulation therapies, and regenerative medicine. Today, exosomes are transitioning from research applications to commercial clinical products and novel drug development, serving as a critical component of precision medicine, cell therapy, and RNA-based therapeutics, attracting significant attention from regulatory agencies and global investors.
The exosome industry is experiencing rapid expansion, driven by surging demand for precision medicine, breakthroughs in liquid biopsy and early diagnostic technologies, and the commercialization of RNA drug delivery platforms. According to reports from leading pharmaceutical and biotech companies, exosomes have been incorporated into oncology, immunology, and neurodegenerative disease pipelines, with several candidates advancing into clinical trials. Capital investment remains strong, and leading CDMO providers are accelerating the development of exosome manufacturing processes and GMP-compliant facilities. Government support for regenerative medicine and advanced therapies is further accelerating the transition of exosomes from research to commercial-scale production. With their natural delivery capabilities and low immunogenicity, exosomes are emerging as a key complement to cell and nucleic acid therapeutics, offering vast market potential.
Despite its high growth potential, the exosome sector faces substantial challenges, including high technical barriers, lack of standardized protocols, and an evolving commercial model. Current isolation and purification techniques remain costly and low-yield, hindering scalability. Global regulatory frameworks are fragmented, with significant variations in quality control, clinical certification, and safety evaluation requirements, slowing commercialization and global market expansion. Additionally, intense competition in intellectual property creates significant entry barriers, particularly for smaller firms. Investor caution over clinical progress and commercialization strategies also introduces uncertainty, emphasizing the need for continuous technological innovation and scalable manufacturing solutions.
Downstream applications are rapidly expanding from research-driven markets to commercial clinical services and therapeutic products. The growth of liquid biopsy is enhancing exosomes’ role as a non-invasive diagnostic biomarker, while their use in drug delivery and immune modulation is improving the precision and safety of cell and gene therapies. The aesthetics and anti-aging markets are also creating new demand for exosome-based products. Advances in AI-driven omics, automated purification platforms, and scalable bioprocessing will enable high-throughput, high-sensitivity, and industrial-scale production. With the rapid growth of precision medicine and RNA therapeutics, exosomes are poised to become a major innovation driver in the biopharmaceutical industry over the next 5–10 years.
This report studies the global Exosomes demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Exosomes, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Exosomes that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Exosomes total market, 2021-2032, (USD Million)
Global Exosomes total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Exosomes total market, key domestic companies, and share, (USD Million)
Global Exosomes revenue by player, revenue and market share 2021-2026, (USD Million)
Global Exosomes total market by Type, CAGR, 2021-2032, (USD Million)
Global Exosomes total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Exosomes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CellResearch, ExoCoBio, Skinlabs Medical, Thermo Fisher Scientific, Qiagen, System Biosciences (SBI), Merck, Norgen Biotek, StemCells21, Codiak Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Exosomes market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Exosomes Market, By Region:
1. How big is the global Exosomes market?
2. What is the demand of the global Exosomes market?
3. What is the year over year growth of the global Exosomes market?
4. What is the total value of the global Exosomes market?
5. Who are the Major Players in the global Exosomes market?
6. What are the growth factors driving the market demand?
Exosomes are nanoscale extracellular vesicles with diameters of approximately 30–150 nanometers, secreted by various cell types through exocytosis under physiological or pathological conditions. Found in biological fluids such as blood, urine, and cerebrospinal fluid, they carry a wide range of biomolecules including proteins, lipids, DNA, mRNA, and miRNA, playing a key role in intercellular communication, immune regulation, tumor progression, tissue repair, and neurodegenerative disease pathways. Advances in nanoscale isolation technologies, biomarker identification, and high-throughput omics research have positioned exosomes as powerful tools for liquid biopsy and early disease diagnosis, as well as promising vectors for targeted drug delivery, immune modulation therapies, and regenerative medicine. Today, exosomes are transitioning from research applications to commercial clinical products and novel drug development, serving as a critical component of precision medicine, cell therapy, and RNA-based therapeutics, attracting significant attention from regulatory agencies and global investors.
The exosome industry is experiencing rapid expansion, driven by surging demand for precision medicine, breakthroughs in liquid biopsy and early diagnostic technologies, and the commercialization of RNA drug delivery platforms. According to reports from leading pharmaceutical and biotech companies, exosomes have been incorporated into oncology, immunology, and neurodegenerative disease pipelines, with several candidates advancing into clinical trials. Capital investment remains strong, and leading CDMO providers are accelerating the development of exosome manufacturing processes and GMP-compliant facilities. Government support for regenerative medicine and advanced therapies is further accelerating the transition of exosomes from research to commercial-scale production. With their natural delivery capabilities and low immunogenicity, exosomes are emerging as a key complement to cell and nucleic acid therapeutics, offering vast market potential.
Despite its high growth potential, the exosome sector faces substantial challenges, including high technical barriers, lack of standardized protocols, and an evolving commercial model. Current isolation and purification techniques remain costly and low-yield, hindering scalability. Global regulatory frameworks are fragmented, with significant variations in quality control, clinical certification, and safety evaluation requirements, slowing commercialization and global market expansion. Additionally, intense competition in intellectual property creates significant entry barriers, particularly for smaller firms. Investor caution over clinical progress and commercialization strategies also introduces uncertainty, emphasizing the need for continuous technological innovation and scalable manufacturing solutions.
Downstream applications are rapidly expanding from research-driven markets to commercial clinical services and therapeutic products. The growth of liquid biopsy is enhancing exosomes’ role as a non-invasive diagnostic biomarker, while their use in drug delivery and immune modulation is improving the precision and safety of cell and gene therapies. The aesthetics and anti-aging markets are also creating new demand for exosome-based products. Advances in AI-driven omics, automated purification platforms, and scalable bioprocessing will enable high-throughput, high-sensitivity, and industrial-scale production. With the rapid growth of precision medicine and RNA therapeutics, exosomes are poised to become a major innovation driver in the biopharmaceutical industry over the next 5–10 years.
This report studies the global Exosomes demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Exosomes, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Exosomes that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Exosomes total market, 2021-2032, (USD Million)
Global Exosomes total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Exosomes total market, key domestic companies, and share, (USD Million)
Global Exosomes revenue by player, revenue and market share 2021-2026, (USD Million)
Global Exosomes total market by Type, CAGR, 2021-2032, (USD Million)
Global Exosomes total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Exosomes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CellResearch, ExoCoBio, Skinlabs Medical, Thermo Fisher Scientific, Qiagen, System Biosciences (SBI), Merck, Norgen Biotek, StemCells21, Codiak Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Exosomes market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Exosomes Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Scientific Research Products
- Beauty and Anti-aging
- Treatment and Diagnosis
- Tumors
- Neurological Diseases
- Regenerative Medicine
- Other
- CellResearch
- ExoCoBio
- Skinlabs Medical
- Thermo Fisher Scientific
- Qiagen
- System Biosciences (SBI)
- Merck
- Norgen Biotek
- StemCells21
- Codiak Biosciences
- Exosome Diagnostics
- Evox Therapeutics
- Aegle Therapeutics
- Danaher
- Lonza
1. How big is the global Exosomes market?
2. What is the demand of the global Exosomes market?
3. What is the year over year growth of the global Exosomes market?
4. What is the total value of the global Exosomes market?
5. Who are the Major Players in the global Exosomes market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Exosomes Introduction
1.2 World Exosomes Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Exosomes Total Market by Region (by Headquarter Location)
1.3.1 World Exosomes Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Exosomes Revenue (2021-2032)
1.3.3 China Based Company Exosomes Revenue (2021-2032)
1.3.4 Europe Based Company Exosomes Revenue (2021-2032)
1.3.5 Japan Based Company Exosomes Revenue (2021-2032)
1.3.6 South Korea Based Company Exosomes Revenue (2021-2032)
1.3.7 ASEAN Based Company Exosomes Revenue (2021-2032)
1.3.8 India Based Company Exosomes Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Exosomes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Exosomes Consumption Value (2021-2032)
2.2 World Exosomes Consumption Value by Region
2.2.1 World Exosomes Consumption Value by Region (2021-2026)
2.2.2 World Exosomes Consumption Value Forecast by Region (2027-2032)
2.3 United States Exosomes Consumption Value (2021-2032)
2.4 China Exosomes Consumption Value (2021-2032)
2.5 Europe Exosomes Consumption Value (2021-2032)
2.6 Japan Exosomes Consumption Value (2021-2032)
2.7 South Korea Exosomes Consumption Value (2021-2032)
2.8 ASEAN Exosomes Consumption Value (2021-2032)
2.9 India Exosomes Consumption Value (2021-2032)
3 WORLD EXOSOMES COMPANIES COMPETITIVE ANALYSIS
3.1 World Exosomes Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Exosomes Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Exosomes in 2025
3.2.3 Global Concentration Ratios (CR8) for Exosomes in 2025
3.3 Exosomes Company Evaluation Quadrant
3.4 Exosomes Market: Overall Company Footprint Analysis
3.4.1 Exosomes Market: Region Footprint
3.4.2 Exosomes Market: Company Product Type Footprint
3.4.3 Exosomes Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Exosomes Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Exosomes Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Exosomes Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Exosomes Consumption Value Comparison
4.2.1 United States VS China: Exosomes Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Exosomes Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Exosomes Companies and Market Share, 2021-2026
4.3.1 United States Based Exosomes Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Exosomes Revenue, (2021-2026)
4.4 China Based Companies Exosomes Revenue and Market Share, 2021-2026
4.4.1 China Based Exosomes Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Exosomes Revenue, (2021-2026)
4.5 Rest of World Based Exosomes Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Exosomes Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Exosomes Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Exosomes Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Scientific Research Products
5.2.2 Beauty and Anti-aging
5.2.3 Treatment and Diagnosis
5.3 Market Segment by Type
5.3.1 World Exosomes Market Size by Type (2021-2026)
5.3.2 World Exosomes Market Size by Type (2027-2032)
5.3.3 World Exosomes Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Exosomes Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Tumors
6.2.2 Neurological Diseases
6.2.3 Regenerative Medicine
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Exosomes Market Size by Application (2021-2026)
6.3.2 World Exosomes Market Size by Application (2027-2032)
6.3.3 World Exosomes Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 CellResearch
7.1.1 CellResearch Details
7.1.2 CellResearch Major Business
7.1.3 CellResearch Exosomes Product and Services
7.1.4 CellResearch Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 CellResearch Recent Developments/Updates
7.1.6 CellResearch Competitive Strengths & Weaknesses
7.2 ExoCoBio
7.2.1 ExoCoBio Details
7.2.2 ExoCoBio Major Business
7.2.3 ExoCoBio Exosomes Product and Services
7.2.4 ExoCoBio Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ExoCoBio Recent Developments/Updates
7.2.6 ExoCoBio Competitive Strengths & Weaknesses
7.3 Skinlabs Medical
7.3.1 Skinlabs Medical Details
7.3.2 Skinlabs Medical Major Business
7.3.3 Skinlabs Medical Exosomes Product and Services
7.3.4 Skinlabs Medical Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Skinlabs Medical Recent Developments/Updates
7.3.6 Skinlabs Medical Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Exosomes Product and Services
7.4.4 Thermo Fisher Scientific Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Qiagen
7.5.1 Qiagen Details
7.5.2 Qiagen Major Business
7.5.3 Qiagen Exosomes Product and Services
7.5.4 Qiagen Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Qiagen Recent Developments/Updates
7.5.6 Qiagen Competitive Strengths & Weaknesses
7.6 System Biosciences (SBI)
7.6.1 System Biosciences (SBI) Details
7.6.2 System Biosciences (SBI) Major Business
7.6.3 System Biosciences (SBI) Exosomes Product and Services
7.6.4 System Biosciences (SBI) Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 System Biosciences (SBI) Recent Developments/Updates
7.6.6 System Biosciences (SBI) Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Exosomes Product and Services
7.7.4 Merck Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Norgen Biotek
7.8.1 Norgen Biotek Details
7.8.2 Norgen Biotek Major Business
7.8.3 Norgen Biotek Exosomes Product and Services
7.8.4 Norgen Biotek Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Norgen Biotek Recent Developments/Updates
7.8.6 Norgen Biotek Competitive Strengths & Weaknesses
7.9 StemCells21
7.9.1 StemCells21 Details
7.9.2 StemCells21 Major Business
7.9.3 StemCells21 Exosomes Product and Services
7.9.4 StemCells21 Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 StemCells21 Recent Developments/Updates
7.9.6 StemCells21 Competitive Strengths & Weaknesses
7.10 Codiak Biosciences
7.10.1 Codiak Biosciences Details
7.10.2 Codiak Biosciences Major Business
7.10.3 Codiak Biosciences Exosomes Product and Services
7.10.4 Codiak Biosciences Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Codiak Biosciences Recent Developments/Updates
7.10.6 Codiak Biosciences Competitive Strengths & Weaknesses
7.11 Exosome Diagnostics
7.11.1 Exosome Diagnostics Details
7.11.2 Exosome Diagnostics Major Business
7.11.3 Exosome Diagnostics Exosomes Product and Services
7.11.4 Exosome Diagnostics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Exosome Diagnostics Recent Developments/Updates
7.11.6 Exosome Diagnostics Competitive Strengths & Weaknesses
7.12 Evox Therapeutics
7.12.1 Evox Therapeutics Details
7.12.2 Evox Therapeutics Major Business
7.12.3 Evox Therapeutics Exosomes Product and Services
7.12.4 Evox Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Evox Therapeutics Recent Developments/Updates
7.12.6 Evox Therapeutics Competitive Strengths & Weaknesses
7.13 Aegle Therapeutics
7.13.1 Aegle Therapeutics Details
7.13.2 Aegle Therapeutics Major Business
7.13.3 Aegle Therapeutics Exosomes Product and Services
7.13.4 Aegle Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Aegle Therapeutics Recent Developments/Updates
7.13.6 Aegle Therapeutics Competitive Strengths & Weaknesses
7.14 Danaher
7.14.1 Danaher Details
7.14.2 Danaher Major Business
7.14.3 Danaher Exosomes Product and Services
7.14.4 Danaher Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Danaher Recent Developments/Updates
7.14.6 Danaher Competitive Strengths & Weaknesses
7.15 Lonza
7.15.1 Lonza Details
7.15.2 Lonza Major Business
7.15.3 Lonza Exosomes Product and Services
7.15.4 Lonza Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Lonza Recent Developments/Updates
7.15.6 Lonza Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Exosomes Industry Chain
8.2 Exosomes Upstream Analysis
8.3 Exosomes Midstream Analysis
8.4 Exosomes Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Exosomes Introduction
1.2 World Exosomes Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Exosomes Total Market by Region (by Headquarter Location)
1.3.1 World Exosomes Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Exosomes Revenue (2021-2032)
1.3.3 China Based Company Exosomes Revenue (2021-2032)
1.3.4 Europe Based Company Exosomes Revenue (2021-2032)
1.3.5 Japan Based Company Exosomes Revenue (2021-2032)
1.3.6 South Korea Based Company Exosomes Revenue (2021-2032)
1.3.7 ASEAN Based Company Exosomes Revenue (2021-2032)
1.3.8 India Based Company Exosomes Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Exosomes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Exosomes Consumption Value (2021-2032)
2.2 World Exosomes Consumption Value by Region
2.2.1 World Exosomes Consumption Value by Region (2021-2026)
2.2.2 World Exosomes Consumption Value Forecast by Region (2027-2032)
2.3 United States Exosomes Consumption Value (2021-2032)
2.4 China Exosomes Consumption Value (2021-2032)
2.5 Europe Exosomes Consumption Value (2021-2032)
2.6 Japan Exosomes Consumption Value (2021-2032)
2.7 South Korea Exosomes Consumption Value (2021-2032)
2.8 ASEAN Exosomes Consumption Value (2021-2032)
2.9 India Exosomes Consumption Value (2021-2032)
3 WORLD EXOSOMES COMPANIES COMPETITIVE ANALYSIS
3.1 World Exosomes Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Exosomes Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Exosomes in 2025
3.2.3 Global Concentration Ratios (CR8) for Exosomes in 2025
3.3 Exosomes Company Evaluation Quadrant
3.4 Exosomes Market: Overall Company Footprint Analysis
3.4.1 Exosomes Market: Region Footprint
3.4.2 Exosomes Market: Company Product Type Footprint
3.4.3 Exosomes Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Exosomes Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Exosomes Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Exosomes Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Exosomes Consumption Value Comparison
4.2.1 United States VS China: Exosomes Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Exosomes Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Exosomes Companies and Market Share, 2021-2026
4.3.1 United States Based Exosomes Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Exosomes Revenue, (2021-2026)
4.4 China Based Companies Exosomes Revenue and Market Share, 2021-2026
4.4.1 China Based Exosomes Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Exosomes Revenue, (2021-2026)
4.5 Rest of World Based Exosomes Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Exosomes Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Exosomes Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Exosomes Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Scientific Research Products
5.2.2 Beauty and Anti-aging
5.2.3 Treatment and Diagnosis
5.3 Market Segment by Type
5.3.1 World Exosomes Market Size by Type (2021-2026)
5.3.2 World Exosomes Market Size by Type (2027-2032)
5.3.3 World Exosomes Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Exosomes Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Tumors
6.2.2 Neurological Diseases
6.2.3 Regenerative Medicine
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Exosomes Market Size by Application (2021-2026)
6.3.2 World Exosomes Market Size by Application (2027-2032)
6.3.3 World Exosomes Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 CellResearch
7.1.1 CellResearch Details
7.1.2 CellResearch Major Business
7.1.3 CellResearch Exosomes Product and Services
7.1.4 CellResearch Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 CellResearch Recent Developments/Updates
7.1.6 CellResearch Competitive Strengths & Weaknesses
7.2 ExoCoBio
7.2.1 ExoCoBio Details
7.2.2 ExoCoBio Major Business
7.2.3 ExoCoBio Exosomes Product and Services
7.2.4 ExoCoBio Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ExoCoBio Recent Developments/Updates
7.2.6 ExoCoBio Competitive Strengths & Weaknesses
7.3 Skinlabs Medical
7.3.1 Skinlabs Medical Details
7.3.2 Skinlabs Medical Major Business
7.3.3 Skinlabs Medical Exosomes Product and Services
7.3.4 Skinlabs Medical Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Skinlabs Medical Recent Developments/Updates
7.3.6 Skinlabs Medical Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Exosomes Product and Services
7.4.4 Thermo Fisher Scientific Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Qiagen
7.5.1 Qiagen Details
7.5.2 Qiagen Major Business
7.5.3 Qiagen Exosomes Product and Services
7.5.4 Qiagen Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Qiagen Recent Developments/Updates
7.5.6 Qiagen Competitive Strengths & Weaknesses
7.6 System Biosciences (SBI)
7.6.1 System Biosciences (SBI) Details
7.6.2 System Biosciences (SBI) Major Business
7.6.3 System Biosciences (SBI) Exosomes Product and Services
7.6.4 System Biosciences (SBI) Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 System Biosciences (SBI) Recent Developments/Updates
7.6.6 System Biosciences (SBI) Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Exosomes Product and Services
7.7.4 Merck Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Norgen Biotek
7.8.1 Norgen Biotek Details
7.8.2 Norgen Biotek Major Business
7.8.3 Norgen Biotek Exosomes Product and Services
7.8.4 Norgen Biotek Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Norgen Biotek Recent Developments/Updates
7.8.6 Norgen Biotek Competitive Strengths & Weaknesses
7.9 StemCells21
7.9.1 StemCells21 Details
7.9.2 StemCells21 Major Business
7.9.3 StemCells21 Exosomes Product and Services
7.9.4 StemCells21 Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 StemCells21 Recent Developments/Updates
7.9.6 StemCells21 Competitive Strengths & Weaknesses
7.10 Codiak Biosciences
7.10.1 Codiak Biosciences Details
7.10.2 Codiak Biosciences Major Business
7.10.3 Codiak Biosciences Exosomes Product and Services
7.10.4 Codiak Biosciences Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Codiak Biosciences Recent Developments/Updates
7.10.6 Codiak Biosciences Competitive Strengths & Weaknesses
7.11 Exosome Diagnostics
7.11.1 Exosome Diagnostics Details
7.11.2 Exosome Diagnostics Major Business
7.11.3 Exosome Diagnostics Exosomes Product and Services
7.11.4 Exosome Diagnostics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Exosome Diagnostics Recent Developments/Updates
7.11.6 Exosome Diagnostics Competitive Strengths & Weaknesses
7.12 Evox Therapeutics
7.12.1 Evox Therapeutics Details
7.12.2 Evox Therapeutics Major Business
7.12.3 Evox Therapeutics Exosomes Product and Services
7.12.4 Evox Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Evox Therapeutics Recent Developments/Updates
7.12.6 Evox Therapeutics Competitive Strengths & Weaknesses
7.13 Aegle Therapeutics
7.13.1 Aegle Therapeutics Details
7.13.2 Aegle Therapeutics Major Business
7.13.3 Aegle Therapeutics Exosomes Product and Services
7.13.4 Aegle Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Aegle Therapeutics Recent Developments/Updates
7.13.6 Aegle Therapeutics Competitive Strengths & Weaknesses
7.14 Danaher
7.14.1 Danaher Details
7.14.2 Danaher Major Business
7.14.3 Danaher Exosomes Product and Services
7.14.4 Danaher Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Danaher Recent Developments/Updates
7.14.6 Danaher Competitive Strengths & Weaknesses
7.15 Lonza
7.15.1 Lonza Details
7.15.2 Lonza Major Business
7.15.3 Lonza Exosomes Product and Services
7.15.4 Lonza Exosomes Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Lonza Recent Developments/Updates
7.15.6 Lonza Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Exosomes Industry Chain
8.2 Exosomes Upstream Analysis
8.3 Exosomes Midstream Analysis
8.4 Exosomes Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Exosomes Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Exosomes Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Exosomes Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Exosomes Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Exosomes Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Exosomes Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Exosomes Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Exosomes Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Exosomes Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Exosomes Players in 2025
Table 12. World Exosomes Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Exosomes Company Evaluation Quadrant
Table 14. Head Office of Key Exosomes Players
Table 15. Exosomes Market: Company Product Type Footprint
Table 16. Exosomes Market: Company Product Application Footprint
Table 17. Exosomes Mergers & Acquisitions Activity
Table 18. United States VS China Exosomes Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Exosomes Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Exosomes Companies, Headquarters (States, Country)
Table 21. United States Based Companies Exosomes Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Exosomes Revenue Market Share (2021-2026)
Table 23. China Based Exosomes Companies, Headquarters (Province, Country)
Table 24. China Based Companies Exosomes Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Exosomes Revenue Market Share (2021-2026)
Table 26. Rest of World Based Exosomes Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Exosomes Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Exosomes Revenue Market Share (2021-2026)
Table 29. World Exosomes Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Exosomes Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Exosomes Market Size by Type (2027-2032) & (USD Million)
Table 32. World Exosomes Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Exosomes Market Size by Application (2021-2026) & (USD Million)
Table 34. World Exosomes Market Size by Application (2027-2032) & (USD Million)
Table 35. CellResearch Basic Information, Manufacturing Base and Competitors
Table 36. CellResearch Major Business
Table 37. CellResearch Exosomes Product and Services
Table 38. CellResearch Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. CellResearch Recent Developments/Updates
Table 40. CellResearch Competitive Strengths & Weaknesses
Table 41. ExoCoBio Basic Information, Manufacturing Base and Competitors
Table 42. ExoCoBio Major Business
Table 43. ExoCoBio Exosomes Product and Services
Table 44. ExoCoBio Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. ExoCoBio Recent Developments/Updates
Table 46. ExoCoBio Competitive Strengths & Weaknesses
Table 47. Skinlabs Medical Basic Information, Manufacturing Base and Competitors
Table 48. Skinlabs Medical Major Business
Table 49. Skinlabs Medical Exosomes Product and Services
Table 50. Skinlabs Medical Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Skinlabs Medical Recent Developments/Updates
Table 52. Skinlabs Medical Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Exosomes Product and Services
Table 56. Thermo Fisher Scientific Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Qiagen Basic Information, Manufacturing Base and Competitors
Table 60. Qiagen Major Business
Table 61. Qiagen Exosomes Product and Services
Table 62. Qiagen Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Qiagen Recent Developments/Updates
Table 64. Qiagen Competitive Strengths & Weaknesses
Table 65. System Biosciences (SBI) Basic Information, Manufacturing Base and Competitors
Table 66. System Biosciences (SBI) Major Business
Table 67. System Biosciences (SBI) Exosomes Product and Services
Table 68. System Biosciences (SBI) Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. System Biosciences (SBI) Recent Developments/Updates
Table 70. System Biosciences (SBI) Competitive Strengths & Weaknesses
Table 71. Merck Basic Information, Manufacturing Base and Competitors
Table 72. Merck Major Business
Table 73. Merck Exosomes Product and Services
Table 74. Merck Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Merck Recent Developments/Updates
Table 76. Merck Competitive Strengths & Weaknesses
Table 77. Norgen Biotek Basic Information, Manufacturing Base and Competitors
Table 78. Norgen Biotek Major Business
Table 79. Norgen Biotek Exosomes Product and Services
Table 80. Norgen Biotek Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Norgen Biotek Recent Developments/Updates
Table 82. Norgen Biotek Competitive Strengths & Weaknesses
Table 83. StemCells21 Basic Information, Manufacturing Base and Competitors
Table 84. StemCells21 Major Business
Table 85. StemCells21 Exosomes Product and Services
Table 86. StemCells21 Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. StemCells21 Recent Developments/Updates
Table 88. StemCells21 Competitive Strengths & Weaknesses
Table 89. Codiak Biosciences Basic Information, Manufacturing Base and Competitors
Table 90. Codiak Biosciences Major Business
Table 91. Codiak Biosciences Exosomes Product and Services
Table 92. Codiak Biosciences Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Codiak Biosciences Recent Developments/Updates
Table 94. Codiak Biosciences Competitive Strengths & Weaknesses
Table 95. Exosome Diagnostics Basic Information, Manufacturing Base and Competitors
Table 96. Exosome Diagnostics Major Business
Table 97. Exosome Diagnostics Exosomes Product and Services
Table 98. Exosome Diagnostics Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Exosome Diagnostics Recent Developments/Updates
Table 100. Exosome Diagnostics Competitive Strengths & Weaknesses
Table 101. Evox Therapeutics Basic Information, Manufacturing Base and Competitors
Table 102. Evox Therapeutics Major Business
Table 103. Evox Therapeutics Exosomes Product and Services
Table 104. Evox Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Evox Therapeutics Recent Developments/Updates
Table 106. Evox Therapeutics Competitive Strengths & Weaknesses
Table 107. Aegle Therapeutics Basic Information, Manufacturing Base and Competitors
Table 108. Aegle Therapeutics Major Business
Table 109. Aegle Therapeutics Exosomes Product and Services
Table 110. Aegle Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Aegle Therapeutics Recent Developments/Updates
Table 112. Aegle Therapeutics Competitive Strengths & Weaknesses
Table 113. Danaher Basic Information, Manufacturing Base and Competitors
Table 114. Danaher Major Business
Table 115. Danaher Exosomes Product and Services
Table 116. Danaher Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Danaher Recent Developments/Updates
Table 118. Danaher Competitive Strengths & Weaknesses
Table 119. Lonza Basic Information, Manufacturing Base and Competitors
Table 120. Lonza Major Business
Table 121. Lonza Exosomes Product and Services
Table 122. Lonza Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Lonza Recent Developments/Updates
Table 124. Lonza Competitive Strengths & Weaknesses
Table 125. Global Key Players of Exosomes Upstream (Raw Materials)
Table 126. Global Exosomes Typical Customers
Table 1. World Exosomes Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Exosomes Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Exosomes Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Exosomes Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Exosomes Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Exosomes Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Exosomes Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Exosomes Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Exosomes Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Exosomes Players in 2025
Table 12. World Exosomes Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Exosomes Company Evaluation Quadrant
Table 14. Head Office of Key Exosomes Players
Table 15. Exosomes Market: Company Product Type Footprint
Table 16. Exosomes Market: Company Product Application Footprint
Table 17. Exosomes Mergers & Acquisitions Activity
Table 18. United States VS China Exosomes Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Exosomes Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Exosomes Companies, Headquarters (States, Country)
Table 21. United States Based Companies Exosomes Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Exosomes Revenue Market Share (2021-2026)
Table 23. China Based Exosomes Companies, Headquarters (Province, Country)
Table 24. China Based Companies Exosomes Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Exosomes Revenue Market Share (2021-2026)
Table 26. Rest of World Based Exosomes Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Exosomes Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Exosomes Revenue Market Share (2021-2026)
Table 29. World Exosomes Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Exosomes Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Exosomes Market Size by Type (2027-2032) & (USD Million)
Table 32. World Exosomes Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Exosomes Market Size by Application (2021-2026) & (USD Million)
Table 34. World Exosomes Market Size by Application (2027-2032) & (USD Million)
Table 35. CellResearch Basic Information, Manufacturing Base and Competitors
Table 36. CellResearch Major Business
Table 37. CellResearch Exosomes Product and Services
Table 38. CellResearch Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. CellResearch Recent Developments/Updates
Table 40. CellResearch Competitive Strengths & Weaknesses
Table 41. ExoCoBio Basic Information, Manufacturing Base and Competitors
Table 42. ExoCoBio Major Business
Table 43. ExoCoBio Exosomes Product and Services
Table 44. ExoCoBio Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. ExoCoBio Recent Developments/Updates
Table 46. ExoCoBio Competitive Strengths & Weaknesses
Table 47. Skinlabs Medical Basic Information, Manufacturing Base and Competitors
Table 48. Skinlabs Medical Major Business
Table 49. Skinlabs Medical Exosomes Product and Services
Table 50. Skinlabs Medical Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Skinlabs Medical Recent Developments/Updates
Table 52. Skinlabs Medical Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Exosomes Product and Services
Table 56. Thermo Fisher Scientific Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Qiagen Basic Information, Manufacturing Base and Competitors
Table 60. Qiagen Major Business
Table 61. Qiagen Exosomes Product and Services
Table 62. Qiagen Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Qiagen Recent Developments/Updates
Table 64. Qiagen Competitive Strengths & Weaknesses
Table 65. System Biosciences (SBI) Basic Information, Manufacturing Base and Competitors
Table 66. System Biosciences (SBI) Major Business
Table 67. System Biosciences (SBI) Exosomes Product and Services
Table 68. System Biosciences (SBI) Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. System Biosciences (SBI) Recent Developments/Updates
Table 70. System Biosciences (SBI) Competitive Strengths & Weaknesses
Table 71. Merck Basic Information, Manufacturing Base and Competitors
Table 72. Merck Major Business
Table 73. Merck Exosomes Product and Services
Table 74. Merck Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Merck Recent Developments/Updates
Table 76. Merck Competitive Strengths & Weaknesses
Table 77. Norgen Biotek Basic Information, Manufacturing Base and Competitors
Table 78. Norgen Biotek Major Business
Table 79. Norgen Biotek Exosomes Product and Services
Table 80. Norgen Biotek Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Norgen Biotek Recent Developments/Updates
Table 82. Norgen Biotek Competitive Strengths & Weaknesses
Table 83. StemCells21 Basic Information, Manufacturing Base and Competitors
Table 84. StemCells21 Major Business
Table 85. StemCells21 Exosomes Product and Services
Table 86. StemCells21 Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. StemCells21 Recent Developments/Updates
Table 88. StemCells21 Competitive Strengths & Weaknesses
Table 89. Codiak Biosciences Basic Information, Manufacturing Base and Competitors
Table 90. Codiak Biosciences Major Business
Table 91. Codiak Biosciences Exosomes Product and Services
Table 92. Codiak Biosciences Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Codiak Biosciences Recent Developments/Updates
Table 94. Codiak Biosciences Competitive Strengths & Weaknesses
Table 95. Exosome Diagnostics Basic Information, Manufacturing Base and Competitors
Table 96. Exosome Diagnostics Major Business
Table 97. Exosome Diagnostics Exosomes Product and Services
Table 98. Exosome Diagnostics Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Exosome Diagnostics Recent Developments/Updates
Table 100. Exosome Diagnostics Competitive Strengths & Weaknesses
Table 101. Evox Therapeutics Basic Information, Manufacturing Base and Competitors
Table 102. Evox Therapeutics Major Business
Table 103. Evox Therapeutics Exosomes Product and Services
Table 104. Evox Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Evox Therapeutics Recent Developments/Updates
Table 106. Evox Therapeutics Competitive Strengths & Weaknesses
Table 107. Aegle Therapeutics Basic Information, Manufacturing Base and Competitors
Table 108. Aegle Therapeutics Major Business
Table 109. Aegle Therapeutics Exosomes Product and Services
Table 110. Aegle Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Aegle Therapeutics Recent Developments/Updates
Table 112. Aegle Therapeutics Competitive Strengths & Weaknesses
Table 113. Danaher Basic Information, Manufacturing Base and Competitors
Table 114. Danaher Major Business
Table 115. Danaher Exosomes Product and Services
Table 116. Danaher Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Danaher Recent Developments/Updates
Table 118. Danaher Competitive Strengths & Weaknesses
Table 119. Lonza Basic Information, Manufacturing Base and Competitors
Table 120. Lonza Major Business
Table 121. Lonza Exosomes Product and Services
Table 122. Lonza Exosomes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Lonza Recent Developments/Updates
Table 124. Lonza Competitive Strengths & Weaknesses
Table 125. Global Key Players of Exosomes Upstream (Raw Materials)
Table 126. Global Exosomes Typical Customers
LIST OF FIGURES
Figure 1. Exosomes Picture
Figure 2. World Exosomes Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Exosomes Total Revenue (2021-2032) & (USD Million)
Figure 4. World Exosomes Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Exosomes Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 13. Exosomes Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 16. World Exosomes Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 18. China Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 23. India Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Exosomes by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Exosomes Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Exosomes Markets in 2025
Figure 27. United States VS China: Exosomes Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Exosomes Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Exosomes Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Exosomes Market Size Market Share by Type in 2025
Figure 31. Scientific Research Products
Figure 32. Beauty and Anti-aging
Figure 33. Treatment and Diagnosis
Figure 34. World Exosomes Market Size Market Share by Type (2021-2032)
Figure 35. World Exosomes Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Exosomes Market Size Market Share by Application in 2025
Figure 37. Tumors
Figure 38. Neurological Diseases
Figure 39. Regenerative Medicine
Figure 40. Other
Figure 41. World Exosomes Market Size Market Share by Application (2021-2032)
Figure 42. Exosomes Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Exosomes Picture
Figure 2. World Exosomes Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Exosomes Total Revenue (2021-2032) & (USD Million)
Figure 4. World Exosomes Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Exosomes Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Exosomes Revenue (2021-2032) & (USD Million)
Figure 13. Exosomes Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 16. World Exosomes Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 18. China Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 23. India Exosomes Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Exosomes by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Exosomes Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Exosomes Markets in 2025
Figure 27. United States VS China: Exosomes Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Exosomes Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Exosomes Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Exosomes Market Size Market Share by Type in 2025
Figure 31. Scientific Research Products
Figure 32. Beauty and Anti-aging
Figure 33. Treatment and Diagnosis
Figure 34. World Exosomes Market Size Market Share by Type (2021-2032)
Figure 35. World Exosomes Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Exosomes Market Size Market Share by Application in 2025
Figure 37. Tumors
Figure 38. Neurological Diseases
Figure 39. Regenerative Medicine
Figure 40. Other
Figure 41. World Exosomes Market Size Market Share by Application (2021-2032)
Figure 42. Exosomes Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
